124.82
price up icon3.12%   3.78
after-market After Hours: 124.82
loading
Revvity Inc stock is traded at $124.82, with a volume of 2.29M. It is up +3.12% in the last 24 hours and up +0.69% over the past month. Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$121.04
Open:
$122.54
24h Volume:
2.29M
Relative Volume:
3.41
Market Cap:
$15.39B
Revenue:
$2.71B
Net Income/Loss:
$169.43M
P/E Ratio:
20.99
EPS:
5.9463
Net Cash Flow:
$382.96M
1W Performance:
+6.24%
1M Performance:
+0.69%
6M Performance:
+24.06%
1Y Performance:
+41.58%
1-Day Range:
Value
$120.75
$128.83
1-Week Range:
Value
$116.39
$128.83
52-Week Range:
Value
$82.17
$128.83

Revvity Inc Stock (RVTY) Company Profile

Name
Name
Revvity Inc
Name
Phone
781-663-5791
Name
Address
940 WINTER STREET, WALTHAM
Name
Employee
11,500
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
RVTY's Discussions on Twitter

Revvity Inc Stock (RVTY) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-16-24 Downgrade UBS Buy → Neutral
Jan-04-24 Upgrade Evercore ISI In-line → Outperform
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Peer Perform
Sep-28-23 Initiated Bernstein Outperform
Jul-19-23 Initiated Raymond James Outperform
May-23-23 Resumed Goldman Buy
View All

Revvity Inc Stock (RVTY) Latest News

pulisher
02:29 AM

Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges - GuruFocus.com

02:29 AM
pulisher
12:58 PM

Q3 2024 Revvity Inc Earnings Call - Mujer es Más

12:58 PM
pulisher
Nov 04, 2024

Revvity Reports Strong Q3 Growth and New Share Buyback - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Earnings call: Revitty reports solid Q3 with $684 million in revenue - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity (NYSE:RVTY) Hits New 52-Week HighHere's Why - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

KeyBanc maintains $132 target on Revvity amid EPS guidance raise By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Inc price target raised to $134 by Evercore ISI - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Inc (RVTY) Shares Up 5.6% on Nov 4 - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Developing image-based T-cell assays for monitoring apoptosis and CAR expression - News-Medical.Net

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity climbs after raising 2024 profit forecast - XM

Nov 04, 2024
pulisher
Nov 04, 2024

Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Adjusts Revenue Forecast But Lifts Profit Expectations - Finimize

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Inc (RVTY) Q3 2024 Earnings: Revenue Hits $684M, GAAP EPS Soars to $0.77, Surpassing Estimates - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity: Q3 Earnings Snapshot - San Antonio Express-News

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity Q3 24 Earnings Conference Call At 8:00 AM ET - Nasdaq

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity beats Q3 expectations, raises full-year EPS outlook By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity earnings beat by $0.15, revenue topped estimates - Investing.com Canada

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity, Inc. Q3 Profit Increases, Beats Estimates - Nasdaq

Nov 04, 2024
pulisher
Nov 04, 2024

Revvity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2024 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

International Assets Investment Management LLC Raises Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Coronation Fund Managers Ltd. Has $11.85 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Ceredex Value Advisors LLC Has $101.07 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Nov 02, 2024
pulisher
Nov 02, 2024

Revvity to Report Q3 Earnings: What's in Store for the Stock? - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 01, 2024
pulisher
Nov 01, 2024

Revvity, Inc. (NYSE:RVTY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Assenagon Asset Management S.A. Trims Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories - Technology Networks

Oct 29, 2024
pulisher
Oct 28, 2024

Bay Colony Advisory Group Inc d b a Bay Colony Advisors Buys Shares of 7,696 Revvity, Inc. (NYSE:RVTY) - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline - Yahoo Finance

Oct 28, 2024
pulisher
Oct 24, 2024

Revvity Board Declares Quarterly Dividend - 01Net

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity Earnings Preview: What to Expect - MSN

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity, Inc. Declares Quarterly Dividend of $0.07 (NYSE:RVTY) - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly - Simply Wall St

Oct 24, 2024
pulisher
Oct 24, 2024

Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga

Oct 24, 2024
pulisher
Oct 24, 2024

Zacks Research Issues Negative Outlook for Revvity Earnings - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Revvity Shares Decline Despite Launch of Transcribe AI Solution - MSN

Oct 24, 2024
pulisher
Oct 22, 2024

Revvity launches AI to digitize handwritten lab forms - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

Revvity launches AI to digitize handwritten lab forms By Investing.com - Investing.com UK

Oct 22, 2024
pulisher
Oct 22, 2024

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report - Business Wire

Oct 22, 2024
pulisher
Oct 21, 2024

CRISPR-based Gene Editing Market Report 2024-2030, - GlobeNewswire

Oct 21, 2024
pulisher
Oct 21, 2024

CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

Revvity Earnings Preview: What To Expect - Barchart

Oct 21, 2024
pulisher
Oct 18, 2024

Revvity Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Oct 18, 2024

Revvity Inc Stock (RVTY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$218.80
price down icon 0.73%
diagnostics_research LH
$227.17
price up icon 0.03%
diagnostics_research WAT
$387.34
price up icon 0.03%
$153.49
price up icon 2.49%
diagnostics_research MTD
$1,364.02
price up icon 1.63%
$414.52
price down icon 0.66%
Cap:     |  Volume (24h):